XML 23 R10.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 28, 2025
Dec. 29, 2024
Cash flows from operating activities from continuing operations    
Net loss $ (45,354) $ (56,451)
Loss from discontinued operations, net of income taxes (1,100) (2,007)
Net loss from continuing operations, net of tax (44,254) (54,444)
Adjustments to reconcile net loss from continuing operations to net cash used in operating activities:    
Stock-based compensation expense 10,488 3,067
Non-cash lease expense 1,365 816
Depreciation and amortization 9,126 2,736
Amortization of debt issuance costs [1] 15,341 5,842
Deferred income tax provision 1,300
Provision for credit losses 3,554 9,132
Change in fair value of SAFE Agreements with related party 151 (616)
Loss on conversion of SAFE Agreements to shares of common stock with related party 1,250
Change in fair value of deferred consideration (560)
Loss on issuance of derivative liability [2] 24,688
Change in fair value of derivative liabilities [3],[4] (11,490) (33,986)
Change in fair value of warrant liabilities 2,800 (2,921)
Change in fair value of forward purchase agreement liabilities [5],[6] 471 (337)
Non-cash expense in connection with warrants issued for vendor services 9,179
Loss on impairments and disposals 113 3,827
Non-cash income [7] (628)
Non-cash interest expense 1,757
Gain on troubled debt restructuring [8] (22,337)
Accretion of debt in CS Solis [9] 3,872
Other financing costs 450
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable (38,756) 3,306
Contract assets, current portion 8,472 (21,451)
Inventories 38,417 8,654
Prepaid expenses and other current assets (4,871) (170)
Other noncurrent assets (664) 111
Accounts payable 15,251 (10,412)
Accrued expenses and other current liabilities (15,913) 14,071
Operating lease liabilities (1,523) (849)
Warranty provision, noncurrent (378) 21
Contract liabilities (3,139) 82
Net cash used in operating activities from continuing operations (15,327) (54,662)
Cash flows from investing activities from continuing operations    
Capitalization of internal-use-software costs (1,157)
Cash paid for acquisitions; net of cash acquired (19,339) (53,500)
Net cash used in investing activities from continuing operations (19,339) (54,657)
Cash flows from financing activities from continuing operations    
Proceeds from issuance of convertible notes, net of issuance cost 20,000 81,725
Proceeds from issuance of convertible notes to related parties 7,000 26,000
Payment of debt issuance costs (200)
Proceeds from issuance of SAFE agreements with related party 6,000
Proceeds from issuance of common stock 6,741 6,694
Proceeds from exercise of common stock options 480 532
Proceeds from exercise of warrant for common stock 60
Investor financing deposit – related party 2,000
Taxes paid related to net share settlement of equity awards (727)
Principal repayment of notes payable (2,157) (300)
Financing lease payments (2,292) (551)
Net cash provided by financing activities from continuing operations 30,905 120,100
Effect of exchange rate changes on cash 22
Net increase (decrease) in cash, cash equivalents and restricted cash (3,761) 10,803
Cash, cash equivalents, and restricted cash at beginning of period 17,219 6,416
Cash, cash equivalents, and restricted cash at end of period 13,458 17,219
Supplemental disclosures of cash flow information:    
Cash paid during the year for interest 7,733 77
Cash paid during the year for income taxes 10
Supplemental schedule of noncash investing and financing activities:    
Issuance of Seller Note as partial purchase consideration for acquisition of Sunder(8) [10] 20,000
Issuance of common stock as partial consideration for acquisition of Sunder 5,700
Deferred consideration recognized for acquisition of Sunder 11,400
Issuance of common stock as partial purchase consideration for acquisition of Ambia 16,493
Deferred consideration recognized for acquisition of Ambia 16,879
Conversion of September 2024 Notes to shares of common stock:    
September 2024 Notes and related derivative liability, net of unamortized debt discount 14,472
Accrued interest 213
Common stock 1
Additional paid-in capital 14,684
Debt issuance costs incurred in connection with the issuance of September 2025 Notes 1,150
Taxes accrued but unpaid related to net share settlement of equity awards 1,171  
Cancellation of existing indebtedness in Exchange Agreement [11] 65,873
Issuance of convertible notes in Exchange Agreement [12] 42,662
Issuance of common stock in Exchange Agreement 2,220
Conversion of SAFE Agreements to shares of common stock – related party 5,000
Operating lease right-of-use assets obtained in exchange for new operating lease liabilities 116
Offering costs 1,396
Warrants issued in debt issuance 860
Carlyle Warrant modification – related party $ 7,306
[1] Amortization of debt issuance costs includes $2.6 million and $1.6 million with related parties in 2025 and 2024, respectively.
[2] Includes $3.0 million loss in 2024 with the Massey Trust (as later defined in Note 10 – Borrowings and Derivative Liabilities), a related party.
[3] Includes $3.5 gain and $0.3 million gain in 2025 and 2024, respectively, in connection with the change in the fair value of derivative liabilities with related parties, the Massey Trust and Carlyle (as later defined in Note 10 – Borrowings and Derivative Liabilities).
[4] Includes a gain of $3.5 million and $0.3 million on the change in the fair value of derivative liabilities with related parties in the fiscal years ended December 28, 2025 and December 29, 2024, respectively. Refer to Note 10 – Borrowings and Derivative Liabilities for details.
[5] Change in fair value of forward purchase agreement liabilities with related parties was income of $0.1 million in each of 2025 and 2024, respectively.
[6] Includes related party income of $0.1 million in each of the years ended December 28, 2025 and December 29, 2024.
[7] Includes related party non-cash income of $0.1 million in 2025.
[8] Gain includes $12.5 million with a related party in 2024. Refer to Note 10 – Borrowings and Derivative Liabilities for details.
[9] Identified as a related party transaction in 2024.
[10] Issuance of Seller Note was deemed to be with a related party. Refer to Note 10. – Borrowings and Derivative Liabilities for details.
[11] Includes related party debt cancellation of $37.2 million.
[12] Includes $23.7 million issuance of convertible notes with related parties.